Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Elfabrioelfabrio.com · Low evidenceElfabrio is an enzyme replacement therapy for adults with Fabry disease, designed to work safely and effectively over the long term. It has a long half-life of approximately 78.9 hours, allowing for infusions every two weeks.
Parse Score